Skip to main content
Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)
OTCMKTS · Delayed Price · Currency is USD
9.36
0.00 (0.00%)
May 6, 2025, 9:30 AM EDT

Revenue by Product

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Contract Research Organization
25.66B
Log In
Log In
Log In
Log In
Contract Research Organization Growth
7.26%
Log In
Log In
Log In
Log In
Medipolis
477.55M
Log In
Log In
Log In
Log In
Medipolis Growth
-20.52%
Log In
Log In
Log In
Log In
Translational Research
11.67M
Log In
Log In
Log In
Log In
Translational Research Growth
-29.19%
Log In
Log In
Log In
Log In
Other
300.45M
Log In
Log In
Log In
Log In
Other Growth
-45.29%
Log In
Log In
Log In
Log In
Preclinical
-
Log In
Log In
Log In
Log In
Preclinical Growth
-
Log In
Log In
Log In
Log In
Clinical
-
Log In
Log In
Log In
Log In
Clinical Growth
-
Log In
Log In
Log In
Log In
Other
300.45M
Log In
Log In
Log In
Log In
Other Growth
-45.29%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Other
393.21M
Log In
Log In
Log In
Log In
Other Growth
-85.61%
Log In
Log In
Log In
Log In
Japan
17.81B
Log In
Log In
Log In
Log In
Japan Growth
-3.80%
Log In
Log In
Log In
Log In
United States
4.48B
Log In
Log In
Log In
Log In
United States Growth
16.62%
Log In
Log In
Log In
Log In
South Korea
3.76B
Log In
Log In
Log In
Log In
Other
393.21M
Log In
Log In
Log In
Log In
Other Growth
-85.61%
Log In
Log In
Log In
Log In